HealthDayStem Cell Transplants May Help Some With Multiple SclerosisHealthDayMONDAY, Feb. 20, 2017 (HealthDay News) — Stem cell transplants may halt the progression of aggressive multiple sclerosis (MS) in nearly half of those with the debilitating di… Continue reading
Post-Bulletin |
Mayo doc’s stem cell experiment blasts into space
Post-Bulletin The stem cells — specialized cells derived from bone marrow — come from Dr. Zubair’s lab. Dr. Zubair, according to a report from the Mayo Clinic, specializes in cellular treatments for disease and regenerative medicine. He hopes to find out how the … |
Newsweek |
Here’s Why Organoids Are a Game Changer in Medical Research
Newsweek Organoids are clusters of cells that organize themselves into mini versions of our organs. They are grown from stem cells, and their use has only become possible with the discovery of the precise conditions needed to keep stem cells alive outside the body. |
BT.com |
Long-term outcomes following stem cell transplant for multiple sclerosis
EurekAlert (press release) A new study published online by JAMA Neurology examines the long-term outcomes of patients with aggressive forms of multiple sclerosis (MS) who failed to respond to standard therapies and who underwent autologous hematopoietic stem cell … New stem cell treatment could ‘freeze’ MS for up to five yearsBT.com Risky treatment can stop multiple sclerosis for yearsBBC News Radical stem cell treatment for MS could stop the disease in its tracks for 5 years and even allow some sufferers to …Daily Mail eMaxHealth all 7 news articles » |
Satellite PR News (press release) |
Synthetic Biology Market Opportunities: Increasing clarity about …
Medgadget (blog) The global synthetic biology market is projected to grow remarkably, says a report from Transparency Market Research (TMR). This report is titled “Syntheti. Synthetic Biology Market Worth USD 37.21 Billion by 2022 – SAT …Satellite PR News (press release) |
Oncology Nurse Advisor |
Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
Oncology Nurse Advisor Patients with MDS produce insufficient amounts of healthy blood cells. “Although donor stem cell transplantation is the only curative therapy for MDS, many patients die after transplantation, largely due to relapse of the disease or complications … |